Tovuti hii inatekeleza vipengele vya msingi kwa sasa na bado haiko tayari kwa matumizi ya wagonjwa.
Tovuti hii inatekeleza vipengele vya msingi kwa sasa na bado haiko tayari kwa matumizi ya wagonjwa.
Kwa madhumuni ya habari pekee — si ushauri wa kitabibu
Ni hatari kiasi gani?
Hatari ya kifo
Ndiyo
Chanjo inapatikana?
Muda hadi dalili
Nchi zilizoathirika
Milipuko hai
Hakikisha kipimo cha kuimarisha cha Tdap ni cha sasa (kila miaka 10). Kifaduro kinaenea duniani kote na milipuko hutokea katika nchi zote. Muhimu hasa ukisafiri na au kutembelea watoto wachanga. "Kikohozi cha siku 100" kinaweza kuathiri sana mipango ya safari.
Maambukizi ya bakteria yanayosababisha mashambulizi ya kikohozi kali na kisirani (whoop) — hatari sana kwa watoto wachanga chini ya miezi 6.
Highly contagious respiratory disease characterized by severe coughing fits.
Kifaduro (pertussis / whooping cough / kikohozi cha mvua) ni ugonjwa wa kuambukiza sana unaosababishwa na bakteria Bordetella pertussis. Kiwango cha kueneza ndani ya nyumba ni 80–90%. Hatari zaidi kwa watoto wachanga chini ya miezi 6 (90% ya vifo). Ugonjwa huu umerudi duniani tangu 2010 kutokana na kupungua kwa kinga baada ya chanjo ya acellular.
Katika Afrika Mashariki, kifaduro bado ni tatizo kubwa la kiafya kwa watoto wachanga. Chanjo ya DTP/Pentavalent katika programu ya EPI inatoa ulinzi, lakini kiwango cha chanjo hakifikii 100% katika maeneo yote. Chanjo ya Tdap kwa mama wajawazito (kila ujauzito) ndiyo mkakati mpya wa kulinda watoto wachanga kabla ya chanjo yao kuanza — lakini bado haijaingizwa rasmi katika programu za EPI za nchi nyingi za Afrika Mashariki.
Mtoto mchanga anayeacha kupumua (apnea) au kuwa bluu (cyanosis). Degedege. Kushindwa kula/kunyonya. Homa >38.5°C pamoja na kikohozi (nimonia). NENDA HOSPITALI MARA MOJA.
Dalili na ishara za kawaida zaidi
Hatua ya mafua (catarrhal phase, wiki 1–2):
Haitofautishwi na mafua ya kawaida — pua inayotoka maji, kupiga chafya, kikohozi kidogo
Homa nyepesi au bila homa
HATUA HII NDIYO YA KUAMBUKIZA ZAIDI
Hatua ya kikohozi (paroxysmal phase, wiki 2–8):
Vipindi vya kikohozi kali cha mfululizo kinachofuatiwa na "whoop" — sauti ya juu ya kuvuta pumzi
Kutapika baada ya kikohozi (post-tussive emesis)
Watoto wachanga: WANAWEZA KUACHA KUPUMUA (apnea) BILA WHOOP — dalili ya hatari
Vipindi vinaweza kuwa 10–30 kwa siku/usiku
Kati ya vipindi, mtoto anaweza kuonekana mzima
Hatua ya kupona (convalescent phase, wiki 2–6+):
Kujua dalili ni hatua ya kwanza kwa mwitikio wa haraka.
Mwenendo wa kawaida wa ugonjwa:
Dalili zisizo za kawaida: Watu wazima na watoto waliopewa chanjo mara nyingi wana kikohozi cha muda mrefu bila "whoop" ya kawaida. Watoto wachanga <miezi 3 wanaweza kujitokeza na apnea badala ya kikohozi.
Jinsi ugonjwa huu unavyotambuliwa
Uchunguzi wa maabara:
PCR ya nasopharyngeal swab — njia bora zaidi, matokeo ndani ya masaa machache
Utamaduni wa Bordetella pertussis (Bordet-Gengou agar) — specific lakini polepole
Serology (IgG anti-PT) — kwa kesi za baadaye (>3 wiki)
Taarifa: Toa taarifa kwa mamlaka ya afya. Uchunguzi wa watu wote waliogusana.
Njia za matibabu zinazopatikana
Antibiotiki:
Azithromycin kwa siku 5 (dawa ya kwanza — salama kwa watoto chini ya mwezi 1)
Clarithromycin kwa siku 7 (mbadala)
Trimethoprim-sulfamethoxazole (ikiwa macrolides hazifai)
Watoto wachanga chini ya miezi 6:
LAZIMA walazwe hospitalini
Ufuatiliaji wa mfumo wa kupumua kwa masaa 24 (apnea monitoring)
Oksijeni ikiwa inahitajika
Msaada wa lishe (ikiwa kutapika kunazuia kulisha)
Kuzuia kwa waliogusana:
Hali nyingi hutibiwa kwa ufanisi kwa utambuzi wa mapema.
Jinsi ya kujilinda
Chanjo:
DTP/Pentavalent katika EPI: Wiki 6, 10, 14 (whole-cell pertussis)
Tdap kwa mama wajawazito kila ujauzito (wiki 20–36) — mkakati bora wa kulinda watoto wachanga
"Mkakati wa kokondi" (cocoon strategy): Chanjo ya watu wote wanaomzunguka mtoto mchanga
Katika Afrika Mashariki:
Pentavalent (DTP-HepB-Hib) katika EPI ya Tanzania na Kenya
Chanjo ya Tdap kwa wajawazito bado haijaingizwa rasmi katika EPI — lakini inapendekezwa
Maandalizi ni ulinzi bora zaidi.
Hakikisha chanjo ya Tdap ni ya hivi karibuni. Mama wajawazito wanaosafiri: Tdap katika kila ujauzito (wiki 27–36 za ujauzito ni bora zaidi). Kuwa mwangalifu na watoto wachanga wasafiri katika maeneo yenye chanjo duni.
Takwimu na data za kijiografia
Duniani: Visa ~24 milioni na vifo ~160,000 kwa mwaka (hasa watoto wachanga). Katika Afrika Mashariki, data kamili ni ngumu kupatikana kwa sababu ya uchunguzi mdogo na ufuatiliaji duni. Tanzania na Kenya: Visa vinatokea kwa mfululizo, na milipuko ya mara kwa mara katika jamii zenye chanjo duni. Mzigo mkubwa katika watoto chini ya mwaka 1 ambao hawajapata chanjo kamili.
Nani yuko hatarini zaidi
Risk factors for pertussis infection and severe outcomes are primarily related to age, vaccination status, and proximity to infectious contacts.
Risk factors for infection:
Waning immunity: Pertussis immunity is not lifelong, whether acquired through vaccination or natural infection. Acellular vaccine protection wanes after 4–6 years; whole-cell vaccine protection after 4–15 years; natural immunity after 7–20 years. This creates large pools of susceptible adolescents and adults who drive ongoing transmission.
Household exposure: Secondary attack rates among susceptible household contacts are 80–90% — among the highest of any infectious disease. The primary source of infant infection is usually a household member (parent, sibling, or grandparent) with unrecognized pertussis.
Incomplete vaccination: Children who have not completed the primary series (3 doses) have substantially higher risk. Even a partial series provides some protection, but full protection requires ≥3 doses.
Crowded settings: Schools, daycare centers, military barracks, dormitories — pertussis outbreaks are frequently school-based.
Epidemic cycles: Pertussis epidemics occur every 3–5 years even in countries with >90% DTP3 coverage, reflecting the accumulation of susceptible individuals as vaccine immunity wanes.
Risk factors for severe disease and death:
Age <6 months: The highest-risk group for severe pertussis, hospitalization, and death. Infants this age have not yet completed the primary vaccine series and may lack protective maternal antibodies (especially if the mother was not vaccinated with Tdap during pregnancy). Apnea, pneumonia, pulmonary hypertension, and encephalopathy are disproportionately common.
Prematurity and low birth weight: Increased risk of severe pertussis due to smaller airways, immature immune function, and lower transplacental antibody transfer.
Absence of maternal Tdap vaccination: Infants born to unvaccinated mothers have 3–5× higher risk of pertussis in the first 2 months of life.
Comorbid respiratory disease: Asthma, bronchopulmonary dysplasia, and other chronic lung conditions may exacerbate the severity and duration of pertussis.
Extreme leukocytosis: WBC >100,000/µL in infants is an independent predictor of mortality, associated with leukostasis, pulmonary hypertension, and refractory hypoxemia.
Risk factors for prolonged cough in adults:
Asthma and chronic respiratory conditions
Active smoking
Advanced age
Immunocompromised status
Matatizo yanayoweza kutokea
Matatizo (hasa kwa watoto wachanga):
Nimonia (sababu kuu ya vifo — 90% ya vifo ni kwa watoto chini ya mwaka 1)
Apnea (kuacha kupumua) — hatari zaidi kwa watoto chini ya miezi 6
Degedege (convulsions)
Encephalopathy (uharibifu wa ubongo)
Mifupa ya mbavu kuvunjika (kutokana na kikohozi kali — kwa watu wazima)
Hernia, rectal prolapse
Kupoteza uzito na utapiamlo
Vifo: Nchi zilizoendelea: <1%. Nchi zinazoendelea (ikiwa ni pamoja na Afrika Mashariki): 1–4% kwa watoto wachanga. Hatari ya juu zaidi kwa watoto ambao hawajachanjwa.
Matokeo yanayotarajiwa na kupona
Watoto wachanga <miezi 6: Magonjwa na vifo vingi zaidi. CFR 1–3% kwa watoto wasiopewa chanjo. Sababu kuu ya vifo vya kikohozi cha mvua.
Watoto wakubwa na watu wazima: Mara chache husababisha kifo lakini husababisha ugonjwa wa muda mrefu. "Kikohozi cha siku 100."
Matatizo:
Nimonia (sababu kuu ya vifo kwa watoto wachanga): 5–10%.
Degedege: 1–2%, kwa kawaida za homa.
Encephalopathy: 0.1–0.3%.
Kuvunjika kwa mbavu, hernia, kutoka damu kwenye jicho (kutokana na kikohozi kali).
Usikivu wa kupindukia wa kikohozi baada ya pertussis unaweza kudumu miezi.
Kinga: Maambukizi ya asili hutoa ulinzi wa miaka 7–20. Kinga inayotokana na chanjo hupungua kwa miaka 5–10.
Ugonjwa huu unazuilika kwa chanjo. Ulinzi madhubuti unapatikana.
Ongea na mtaalamu wa afya ya usafiri kuhusu ratiba inayopendekezwa kabla ya safari yako.
Tafuta kliniki ya chanjo →Maudhui katika ukurasa huu ni kwa madhumuni ya habari na elimu pekee. Hayaundi ushauri wa kitabibu, utambuzi, au mapendekezo ya matibabu. Ikiwa una wasiwasi wa kiafya, wasiliana na mtaalamu wa afya aliyeidhinishwa. SafeTripVax si mtoa huduma za matibabu.
Masharti kamili ya matumiziRecent epidemiological data from the World Health Organization Global Health Observatory.
Source: WHO GHO OData ↗
And 15 more records
This data is provided for informational purposes. Please consult official WHO sources for the most current information.
View WHO data source →Unajua chanjo unayohitaji? Vizuri. Hujui? Tuambie tu unaenda wapi — tutapata chanjo zinazofaa na kliniki. Bure, bila masharti.